Company Filing History:
Years Active: 2019
Title: Ayse Sahaboglu Tekgoz: Innovator in Targeted Drug Delivery
Introduction
Ayse Sahaboglu Tekgoz is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of drug delivery systems, particularly in the treatment of retinal diseases. Her innovative approach focuses on enhancing the efficacy of therapeutic agents through targeted delivery mechanisms.
Latest Patents
Ayse holds a patent for her invention titled "Targeted liposomal delivery of cGMP analogues." This invention relates to methods and means for targeted drug delivery across the blood-ocular barrier. Specifically, it involves cyclic guanosine-3', 5'-monophosphate analogs as therapeutic agents for treating retinal diseases. The invention utilizes glutathione-based ligands to facilitate specific binding and enhanced internalization by glutathione transporters present on the blood-ocular barrier. These ligands are conjugated to nanocontainers, such as liposomes, which encapsulate the cGMP analogs.
Career Highlights
Ayse is currently associated with Mireca Medicines GmbH, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing quest to improve drug delivery systems, particularly for challenging medical conditions.
Collaborations
Ayse collaborates with notable colleagues, including Per Ekström and François Paquet-Durand. These partnerships enhance her research capabilities and contribute to the innovative solutions being developed in her field.
Conclusion
Ayse Sahaboglu Tekgoz is a trailblazer in the realm of targeted drug delivery, with her patent showcasing her commitment to advancing medical science. Her work has the potential to significantly impact the treatment of retinal diseases and improve patient outcomes.